During session VI at Myeloma2018, Kyohei Nakamura, MD, PhD, Bruno Paiva, PhD, and Marta Chesi, PhD, present stimulating evidence of the role the immune microenvironment plays in MM progression.
Key questions are asked on how understanding tumor-promoting inflammation could potentially present opportunities for therapeutic targeting, and how a mouse model of human cereblon could be useful in predicting survival outcomes from immunomodulatory drug treatment in MM.
QIMR Berghofer Medical Research Institute, Brisbane, Australia
Kyohei Nakamura, MD, PhD, from the QIMR Berghofer Medical Research Institute, Brisbane, Australia, discusses the microenvironment in myeloma.
University of Navarra, Pamplona, Spain
Bruno Paiva, PhD, from the University of Navarra, Pamplona, Spain, talks about the immune microenvironment.
Mayo Clinic, Scottsdale, AZ
Marta Chesi, PhD, from the Clinic, Scottsdale, AZ, explores optimizing immunotherapy in multiple myeloma.